Expression of cell cycle regulators in human cutaneous malignant melanoma

Melanoma Research

Volumn 9, Issue 2, 1999, Pages 148-154

  Tang, L ^a   Li, G ^a   Tron, V A ^a   Trotter, M J ^a   Ho, V C ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

CDC25; CDK; Cell cycle control; Cyclin; Malignant melanoma

Indexed keywords

CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; PHOSPHATASE;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MELANOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

BLOTTING, WESTERN; CDC2-CDC28 KINASES; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION; HUMANS; MELANOMA; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032772629     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199904000-00006     Document Type: Article

References (44)

1. Lees E. Cyclin-dependent kinase regulation. Curr Opin Cell Biol 1995; 7: 773-780.
2. Morgan D. Principles of CDK regulation. Nature 1995; 374: 131-131.
3. Solomon MJ. Activation of the various cyclin/CDC2 protein kinases. Curr Opin Cell Biol 1993; 5: 180-186.
4. Nigg EA. Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 1993; 5: 187-193.
5. Bartek J, Bertkov J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996; 8: 805-814.
6. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
7. Inohara S, Kitagawa K, Kitano Y. Target of skin tumorigenesis: cyclin D1-CDK4. Int J Dermatol 1996; 35: 609-613.
8. Kamb A. Cell cycle regulators and cancer. Trends Genet 1995; 11: 136-110.
9. Sherr CJ. Cancer cell cycle. Science 1996; 274: 1672-1677.
10. Strauss M, Lukas J, Bartek J. Unrestricted cell cycle and cancer. Nature Med 1995; 1: 1245-1246.
11. Hunter T, Pines J. Cyclins and cancer. Cell 1991; 66: 1071-1074.
12. Hunter T, Pines J. Cyclins and cancer, II: CDK inhibitors come of age. Cell 1994; 79: 573-582.
13. Albino AP. Genes involved in melanoma susceptibility and progression. Curr Opin Oncol 1995; 7: 161-169.
14. Bartkova J, Lukas J, Guldberg P, et al. The p16-cyclin D/CDK4-pRb pathways as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 1996; 56: 5475-5483.
15. Bishop JAN. Molecular pathology of melanoma. Cancer Metastasis Rev 1997; 16: 141-154.
16. Hayward NK. The current situation with regard to human melanoma and genetic interference. Curr Opin Oncol 1996; 8: 136-142.
17. Kamb A, Gruis NA, Weaver-Feldhaus G, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
18. Kraehn GM, Scharlt M, Peter RU. Human malignant melanoma: a genetic disease? Cancer 1995; 75: 1228-1237.
19. Dracopoli N, Fountain JW. CDKN2 mutations in melanoma. Cancer Surv 1996; 26: 115-129.
20. Ohta M, Nagai H, Simizu, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor genes, CDK4I, in melanoma. Cancer Res 1994; 54: 5269-5272.
21. Cordon-Cardo C. Mutation of the cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995; 147: 545-560.
22. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases and CDK inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108.
23. Johnson DG, Richie ER, Conti CJ. The cell cycle and cancer. Cancer Bull 1995; 47: 480-485.
24. Gilchrest BA, Vrabel MA, Flynn E. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 1984; 83: 370-376.
25. Byers HR, Eton T, Doherty JR, et al. Cultured human primary, recurrent cutaneous and metastatic melanoma: time-lapse and image analysis. Am J Pathol 1991; 139: 423-435.
26. cip1 in cutaneous malignant melanoma. J Cutan Pathol 1997; 24: 265-271.
27. Yamamoto H, Monden T, Ikeda H, et al. Co-expression of CDK2/CDC2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995; 71: 1231-1236.
28. Jinno S, Nagata A, Igarashi M, et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J 1994; 13: 1549-1559.
29. Terada Y, Tatsuka M, Jinno S, et al. Requirement for tyrosine phosphorylation of CDK4 in G1 arrest induced by ultraviolet irradiation. Nature 1995; 376: 358-362.
30. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995; 269: 1281-1284.
31. Galaktionov K, Jessus C, Beach D. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 1995; 9: 1046-1058.
32. Sgambatto A, Han EKH, Zhang YJ, et al. Deregulated expression of cyclin D1 and other cell cycle related genes in carcinogen-induced rat mammary tumors. Carcinogenesis 1995; 16: 2193-2198.
33. Galaktionov K, Lee AK, Eckstein J, et al. CDC25 phosphatase as a potential human oncogene. Science 1995; 269: 1575-1577.
34. Gasparatto D, Masestro R, Piccinin S, et al. Overexpression of CDC25A und CDC25B in head and neck cancers. Cancer Res 1997; 57: 2366-2368.
35. Galaktionov K, Chen X, Beach D. CDC25 cell cycle phosphatase as a target of c-Myc. Nature 1996; 382: 511-517.
36. Peris K, Cerroni J, Chimenti S, et al. Proto-oncogene expression in dermal nevi and melanomas. Arch Dermatol Res 1991; 233: 500-505.
37. Latham KM, Eastan SW, Wong A, et al. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases. Mol Cell Biol 1996; 16: 4445-4455.
38. Sparrow LE, Soong R, Dawkins HJS, et al. P53 gene mutation and expression in nevi and melanomas. Melanoma Res 1995; 5: 93-100.
39. Wang Y, Becker D. Differential expression of the cyclin-dependent kinase inhibitor p16 and p21 in the human melanocytic system. Oncogene 1996; 12: 1069-1075.
40. INK4 proteins in cutaneous malignant melanoma. Br J Dermatol 1996; 134: 269-275.
41. Keyomarski K, O'Leary N, Molnar G, et al. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994; 54: 380-385.
42. Nielsen NH, Emdin SO, Cajander J, et al. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997; 14: 295-304.
43. Mælandsmo GM, Florences VA, Hovig E, et al. Involvement of the pRb/p16/CDK4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanoma. Br J Cancer 1996; 73: 909-916.
44. Clark WH, Elder DE, Guerry D, et al. A study of tumor progression: the precursor lesions of superfacial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147-1165.